Aurobindo Pharma Australia Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

Aurobindo Pharma Australia General Information

Description

Manufacturer of semi-synthetic penicillin. The company also supply medicines for neurosciences, cardiovascular, anti-retrovirals, anti-diabetics, gastroenterology and cephalosporins diseases.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • P.O. Box Number:-4039, Macquarie Shopping Centre
  • North Ryde
  • Sydney, New South Wales
  • Australia
Primary Industry
Drug Delivery
Other Industries
Drug Discovery
Acquirer
Eris Pharma
Vertical(s)
Manufacturing, Life Sciences
Corporate Office
  • P.O. Box Number:-4039, Macquarie Shopping Centre
  • North Ryde
  • Sydney, New South Wales
  • Australia

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Aurobindo Pharma Australia Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Aurobindo Pharma Australia‘s full profile, request access.

Request a free trial

Aurobindo Pharma Australia Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Aurobindo Pharma Australia‘s full profile, request access.

Request a free trial

Aurobindo Pharma Australia FAQs

  • Where is Aurobindo Pharma Australia headquartered?

    Aurobindo Pharma Australia is headquartered in Sydney, Australia.

  • What industry is Aurobindo Pharma Australia in?

    Aurobindo Pharma Australia’s primary industry is Drug Delivery.

  • Is Aurobindo Pharma Australia a private or public company?

    Aurobindo Pharma Australia is a Private company.

  • What is Aurobindo Pharma Australia’s current revenue?

    The current revenue for Aurobindo Pharma Australia is 000000.

  • Who are Aurobindo Pharma Australia’s investors?

    Aurobindo Pharma has invested in Aurobindo Pharma Australia.

  • When was Aurobindo Pharma Australia acquired?

    Aurobindo Pharma Australia was acquired on 10-Apr-2015.

  • Who acquired Aurobindo Pharma Australia?

    Aurobindo Pharma Australia was acquired by Eris Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »